All News

    FDA Grants Fast Track Designation for Abenacianine in Lung Cancer Surgery

    January 11th 2025, 7:00pm

    Article

    The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally invasive surgery.

    A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval

    January 11th 2025, 3:00pm

    Article

    Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

    The Impact of Yescarta on Long Term Quality of Life in R/R Follicular Lymphoma

    January 10th 2025, 10:00pm

    Video

    Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.

    P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia

    January 10th 2025, 8:00pm

    Article

    P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.

    Learning to ‘Let it Be’ After Poor Test Results

    January 10th 2025, 6:00pm

    Article

    When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.

    Peter Yarrow Dies of Bladder Cancer, Dick Vitale Cleared for ESPN Return and More

    January 10th 2025, 4:00pm

    Article

    From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, here is this week’s news.

    First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer

    January 10th 2025, 2:00pm

    Article

    For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.

    FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma

    January 9th 2025, 10:00pm

    Article

    The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with relapsed/refractory osteosarcoma.

    Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs

    January 9th 2025, 8:00pm

    Article

    Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.

    A New Year, A New Approach to Survivorship After Cancer

    January 9th 2025, 6:00pm

    Article

    As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and my hopes for the future.